Now showing items 29-48 of 4733

      Title
      A20 deficiency in hematopoietic stem cells causes lymphopenia and myeloproliferation due to elevated Interferon-γ signals [1]
      A20 deficiency in multipotent progenitors perturbs quiescence of hematopoietic stem cells [1]
      AAPM Task Group 264: The safe clinical implementation of MLC tracking in radiotherapy [1]
      ABCG2 polymorphisms in gout: Insights into disease susceptibility and treatment approaches [1]
      The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion [1]
      Abdominal Wall Transplantation: Indications and Outcomes [1]
      Aberrant anterior cingulate processing of anticipated threat as a mechanism for psychosis [1]
      Aberrant Correlation Between the Default Mode and Salience Networks in Mild Traumatic Brain Injury [1]
      Aberrant development of excitatory circuits to inhibitory neurons in the primary visual cortex after neonatal binocular enucleation [1]
      Aberrantly High Levels of Somatic LINE-1 Expression and Retrotransposition in Human Neurological Disorders [1]
      Ablation of TRPV11 afferent terminals by capsaicin mediates long-lasting analgesia for trigeminal neuropathic pain [1]
      ABM Clinical Protocol #32: Management of Hyperlactation [1]
      Abnormal amygdala subregional-sensorimotor connectivity correlates with positive symptom in schizophrenia [1]
      Abnormal Development of the Earliest Cortical Circuits in a Mouse Model of Autism Spectrum Disorder [1]
      Abnormal Innate Immunity in Acute-on-Chronic Liver Failure: Immunotargets for Therapeutics [1]
      Abnormalities in Brain and Muscle Microstructure and Neurochemistry of the DMD Rat Measured by in vivo Diffusion Tensor Imaging and High Resolution Localized 1H MRS [1]
      Absence of synemin in mice causes structural and functional abnormalities in heart [1]
      Academic Achievement, Professionalism, and Burnout in Family Medicine Residents [1]
      Accelerated vaccine rollout is imperative to mitigate highly transmissible COVID-19 variants [1]
      Accelerating Development of SARS-CoV-2 Vaccines — The Role for Controlled Human Infection Models [1]